Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 172
9
Diseases
44
Unique genes
0.164
Avg. similarity score
Dystonia
Most-connected disease (8 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Dystonia
Dystonia musculorum deformans
Genetic torsion dystonia
Torsion dystonia
Early-onset generalized limb-onset dystonia
complex movement disorder with or without neurodevelopmental features
Focal dystonia
X-linked dystonia-parkinsonism
Cervical dystonia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Dystonia | 8 | 8 | 44 |
| Dystonia musculorum deformans | 7 | 7 | 9 |
| Genetic torsion dystonia | 7 | 7 | 9 |
| Torsion dystonia | 6 | 6 | 7 |
| Early-onset generalized limb-onset dystonia | 4 | 4 | 3 |
| complex movement disorder with or without neurodevelopmental features | 4 | 4 | 1 |
| Focal dystonia | 3 | 3 | 1 |
| X-linked dystonia-parkinsonism | 3 | 3 | 1 |
| Cervical dystonia | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HPCA | 5 / 9 | complex movement disorder with or without neurodevelopmental features, Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia and 1 more |
| TOR1A | 5 / 9 | Dystonia, Dystonia musculorum deformans, Early-onset generalized limb-onset dystonia, Genetic torsion dystonia and 1 more |
| GNAL | 4 / 9 | Dystonia, Dystonia musculorum deformans, Focal dystonia, Genetic torsion dystonia |
| TAF1 | 4 / 9 | Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia, X-linked dystonia-parkinsonism |
| THAP1 | 4 / 9 | Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia, Torsion dystonia |
| TUBB4A | 4 / 9 | Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia, Torsion dystonia |
| CIZ1 | 3 / 9 | Cervical dystonia, Dystonia, Torsion dystonia |
| COL6A3 | 3 / 9 | Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia |
| EIF2AK2 | 3 / 9 | Dystonia, Early-onset generalized limb-onset dystonia, Torsion dystonia |
| GCH1 | 3 / 9 | Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia |
| SGCE | 3 / 9 | Dystonia, Dystonia musculorum deformans, Genetic torsion dystonia |
| SHQ1 | 3 / 9 | Dystonia, Early-onset generalized limb-onset dystonia, Torsion dystonia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Folate biosynthesis | KEGG | 3 / 28 | 29.2× | 1.41e-4 | 2.96e-3 ✓ sig. |
| Efferocytosis | KEGG | 5 / 157 | 8.7× | 2.58e-4 | 4.76e-3 ✓ sig. |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | Reactome | 2 / 11 | 49.6× | 7.07e-4 | 1.04e-2 ✓ sig. |
| Inhibition of PKR | Reactome | 1 / 1 | 273× | 3.66e-3 | 3.54e-2 ✓ sig. |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | Reactome | 1 / 1 | 273× | 3.66e-3 | 3.54e-2 ✓ sig. |
| Insulin secretion | KEGG | 3 / 86 | 9.5× | 3.80e-3 | 3.64e-2 ✓ sig. |
| Bile secretion | KEGG | 3 / 90 | 9.1× | 4.32e-3 | 3.98e-2 ✓ sig. |
| RHO GTPases activate IQGAPs | Reactome | 2 / 32 | 17.1× | 6.07e-3 | 4.97e-2 ✓ sig. |
| Degradation of GABA | Reactome | 1 / 2 | 136× | 7.31e-3 | 5.62e-2 |
| Serotonergic synapse | KEGG | 3 / 115 | 7.1× | 8.52e-3 | 6.22e-2 |
| Recycling pathway of L1 | Reactome | 2 / 40 | 13.6× | 9.37e-3 | 6.59e-2 |
| Nicotine addiction | KEGG | 2 / 41 | 13.3× | 9.82e-3 | 6.79e-2 |
| Thyroid hormone signaling pathway | KEGG | 3 / 122 | 6.7× | 1.00e-2 | 6.84e-2 |
| Cytoskeleton in muscle cells | KEGG | 4 / 232 | 4.7× | 1.01e-2 | 6.87e-2 |
| Lactose synthesis | Reactome | 1 / 3 | 91.0× | 1.10e-2 | 7.25e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| neuromuscular process controlling posture | GO:0050884 | 3 / 15 | 84.9× | 5.43e-6 | 3.21e-4 ✓ sig. |
| tetrahydrobiopterin biosynthetic process | GO:0006729 | 2 / 8 | 106× | 1.50e-4 | 4.10e-3 ✓ sig. |
| dopamine biosynthetic process | GO:0042416 | 2 / 9 | 94.4× | 1.93e-4 | 4.93e-3 ✓ sig. |
| inhibitory postsynaptic potential | GO:0060080 | 2 / 10 | 84.9× | 2.41e-4 | 5.77e-3 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 6 / 404 | 6.3× | 3.47e-4 | 7.42e-3 ✓ sig. |
| regulation of SNARE complex assembly | GO:0035542 | 2 / 12 | 70.8× | 3.52e-4 | 7.48e-3 ✓ sig. |
| intracellular cholesterol transport | GO:0032367 | 2 / 13 | 65.3× | 4.16e-4 | 8.44e-3 ✓ sig. |
| vacuole organization | GO:0007033 | 2 / 13 | 65.3× | 4.16e-4 | 8.44e-3 ✓ sig. |
| endosomal vesicle fusion | GO:0034058 | 2 / 15 | 56.6× | 5.58e-4 | 1.03e-2 ✓ sig. |
| response to hypoxia | GO:0001666 | 4 / 176 | 9.7× | 7.69e-4 | 1.27e-2 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 7 / 667 | 4.5× | 8.67e-4 | 1.37e-2 ✓ sig. |
| nitric oxide biosynthetic process | GO:0006809 | 2 / 23 | 36.9× | 1.33e-3 | 1.79e-2 ✓ sig. |
| positive regulation of norepinephrine uptake | GO:0051623 | 1 / 1 | 425× | 2.35e-3 | 2.48e-2 ✓ sig. |
| cellular response to cytochalasin B | GO:0072749 | 1 / 1 | 425× | 2.35e-3 | 2.48e-2 ✓ sig. |
| pteridine-containing compound biosynthetic process | GO:0042559 | 1 / 1 | 425× | 2.35e-3 | 2.48e-2 ✓ sig. |